GSK Issues Statement on SFO Investigation
By

GlaxoSmithKline plc reported that is has been informed by the UK's Serious Fraud Office (SFO), an independent government agency, that the SFO has opened a formal criminal investigation into the group's commercial practices.

In a statement, the company said: “GSK is committed to operating its business to the highest ethical standards and will continue to cooperate fully with the SFO.”

Source: GlaxoSmithKline and the SFO

Leave a Reply

Your email address will not be published. Required fields are marked *